|
Median age at enrollment (N = 232/1 missing data)
|
Median [IQR]
|
31 [26–45]
|
40 [32–47]
|
37 [30–45]
|
|
Median age at the time of TB diagnosis, years (N = 251/1 missing data)
|
Median [IQR]
|
32 [28–39]
|
40 [32–48]
|
37 [31–45]
|
|
Region of origin (N = 223/10 missing data)
|
N. (%)
| | | |
|
Germany
| |
8 (12.5)
|
81 (50.9)
|
89 (39.9)
|
|
Sub-Saharan Africa
| |
41 (64.1)
|
41 (25.8)
|
82 (36.8)
|
|
Other countries
| |
15 (23.4)
|
37 (23.3)
|
52 (23.3)
|
|
HIV-transmission risk group (N = 214/19 missing data)
|
N. (%)
| | | |
|
MSM
| |
---
|
67 (43.8)
|
67 (31.3)
|
|
PWID
| |
3 (4.9)
|
17 (11.1)
|
20 (9.4)
|
|
HPC
| |
54 (88.5)
|
43 (28.1)
|
97 (45.3)
|
|
Others†
| |
4 (6.6)
|
26 (16.9)
|
30 (14.0)
|
|
Median CD4+ blood cell count at enrollment (N = 221/12 missing data)
|
Median [IQR]
|
197 [67–349]
|
204 [67–375]
|
189 [66–348]
|
|
Median CD4+ blood cell count at the time of TB diagnosis (N = 194/39 missing data)
|
Median [IQR]
|
211 [65–339]
|
198 [47–339]
|
216 [69–350]
|
|
Median viral load at enrollment (log10copies/ml) (N = 210/23 missing data)
|
Median [IQR]
|
4.8 [3.6-5.4]
|
4.7 [3.4-5.5]
|
4.9 [3.6-5.3]
|
|
Median viral load at the time of TB diagnosis (N = 145/88 missing data)
|
Median [IQR]
|
5.0 [4.3-5.6]
|
5.2 [4.5-5.7]
|
5.9 [3.9-5.5]
|
|
Hepatitis B* (N = 233)
|
Median [IQR]
|
25 (37.9)
|
39 (23.4)
|
64 (27.5)
|
|
Hepatitis C* (N = 233)
|
Median [IQR]
|
5 (7.6)
|
18 (10.8)
|
23 (9.9)
|
|
Diabetes mellitus* (N = 233)
|
Median [IQR]
|
2 (3.0)
|
5 (3.0)
|
7 (3.0)
|
|
cART‡ (N = 233)
|
Median [IQR]
|
31 (50.0)
|
99 (59.3)
|
130 (55.8)
|
|
Died (N = 233)
|
N. (%)
|
4 (10.6)
|
18 (10.8)
|
25 (10.7)
|
